FINANCIAL CONFLICTS OF INTEREST IN BIOMEDICAL RESEARCH: THE NEED TO IMPROVE THE SYSTEM

被引:1
|
作者
Wang, Amy T. [1 ,4 ]
Montori, Victor M. [1 ,2 ]
Murad, Mohammad Hassan [1 ,3 ]
机构
[1] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA
[2] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA
[3] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN 55905 USA
[4] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA
关键词
COMPETING INTERESTS; TRIALS; ASSOCIATION; REPRESENTATIVES; CONCLUSIONS; PHYSICIANS; US;
D O I
10.1358/dnp.2010.23.9.1521763
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians and researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 50 条